Trial
NCT05134740
(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Baylor College of Medicine
Collaborators
Center for Cell and Gene Therapy, Baylor College of Medicine
Condition
Hodgkins Lymphoma
Intervention
TAA-specific CTLs
Why stopped
Leadership determination
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-22